4//SEC Filing
ODINK DEBRA 4
Accession 0001104659-12-015654
CIK 0001316175other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:01 PM ET
Size
5.9 KB
Accession
0001104659-12-015654
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Sale
Common Stock
2012-03-01$6.57/sh−2,000$13,140→ 26,659 total
Holdings
- 95,928(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001281719
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:01 PM ET
- Size
- 5.9 KB